Several lines of evidence indicate that niclosamide inhibits tumor cell growth by interrupting multiple pathways (Wnt, Notch, STAT3, NF-κB, and mTORc1) and the generation of reactive oxygen species in several cancer cells [16–18, 42–44]. The gene discussed is STAT3; the disease is neoplasm.